+Compare
INGN
Stock ticker:
NASDAQ
AS OF
Aug 5 closing price
Price
$27.71
Change
-$0.93 (-3.25%)
Capitalization
632.78M

INGN Price Prediction, Inogen AI Recommendations

Stock market charts, price targets, analyst ratings and a financial calendar
AI
A.I.Advisor
a Summary for AAPL with price predictions
12:00 AM EDT Aug 05, 2022

INGN saw its Stochastic Oscillator recovers from the overbought zone

The Stochastic Oscillator for INGN moved out of overbought territory on August 05, 2022. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 60 similar instances where the indicator exited the overbought zone. In 47 of the 60 cases the stock moved lower. This puts the odds of a downward move at 78%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for INGN moved out of overbought territory on August 04, 2022. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 40 similar instances where the indicator moved out of overbought territory. In of the 40 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where INGN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

INGN broke above its upper Bollinger Band on August 02, 2022. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 01, 2022. You may want to consider a long position or call options on INGN as a result. In of 73 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for INGN just turned positive on August 01, 2022. Looking at past instances where INGN's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .

INGN moved above its 50-day moving average on July 06, 2022 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for INGN crossed bullishly above the 50-day moving average on July 07, 2022. This indicates that the trend has shifted higher and could be considered a buy signal. In of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where INGN advanced for three days, in of 317 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 235 cases where INGN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. INGN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.766) is normal, around the industry mean (17.059). P/E Ratio (71.429) is within average values for comparable stocks, (93.546). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (6.752). Dividend Yield (0.000) settles around the average of (0.022) among similar stocks. P/S Ratio (1.784) is also within normal values, averaging (92.278).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. INGN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.

AI
A.I.Advisor
published price charts
AI
A.I. Advisor
published Earnings

INGN is expected to report earnings to rise 102.67% to -30 cents per share on November 08

Inogen INGN Stock Earnings Reports
Q3'22
Est.
$-0.30
Q2'22
Beat
by $0.22
Q1'22
Missed
by $0.15
Q4'21
Missed
by $0.28
Q3'21
Beat
by $0.78
The last earnings report on August 04 showed earnings per share of -15 cents, beating the estimate of -37 cents. With 192.59K shares outstanding, the current market capitalization sits at 632.78M.
AI
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Medtronic plc (NYSE:MDT), Intuitive Surgical (NASDAQ:ISRG), Edwards Lifesciences Corp (NYSE:EW), Boston Scientific Corp (NYSE:BSX), IQVIA Holdings (NYSE:IQV), Illumina (NASDAQ:ILMN), Align Technology (NASDAQ:ALGN), Exact Sciences Corp (NASDAQ:EXAS), Guardant Health (NASDAQ:GH).

Industry description

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

Market Cap

The average market capitalization across the Medical Specialties Industry is 6.23B. The market cap for tickers in the group ranges from 775 to 3.82T. MKYSF holds the highest valuation in this group at 3.82T. The lowest valued company is BIIO at 775.

High and low price notable news

The average weekly price growth across all stocks in the Medical Specialties Industry was 6%. For the same Industry, the average monthly price growth was 9%, and the average quarterly price growth was -16%. APDN experienced the highest price growth at 722%, while HSDT experienced the biggest fall at -44%.

Volume

The average weekly volume growth across all stocks in the Medical Specialties Industry was 55%. For the same stocks of the Industry, the average monthly volume growth was 3% and the average quarterly volume growth was 55%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 73
Price Growth Rating: 53
SMR Rating: 67
Profit Risk Rating: 83
Seasonality Score: 2 (-100 ... +100)
AI

View a ticker or compare two or three

AI
A.I. Advisor
published General Information

General Information

a medical technology company

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
301 Coromar Drive
Phone
+1 805 562-0500
Employees
280
Web
https://www.inogen.com

Interesting Tickers

1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WFDSX27.800.15
+0.54%
Allspring Discovery SMID Cap Gr Inst
RYCVX119.210.52
+0.44%
Rydex Dow 2x Strategy H
NSCFX47.670.19
+0.40%
Nuveen Small-Cap Value Opps R6
JEQIX33.960.06
+0.18%
Johnson Equity Income
TRGZX36.410.01
+0.03%
T. Rowe Price Emerging Markets Stock Z

INGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, INGN has been loosely correlated with NVRO. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if INGN jumps, then NVRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INGN
1D Price
Change %
INGN100%
-3.25%
NVRO - INGN
52%
Loosely correlated
+3.63%
AXNX - INGN
46%
Loosely correlated
-1.76%
RMD - INGN
41%
Loosely correlated
+1.30%
SILK - INGN
41%
Loosely correlated
+1.17%
CERS - INGN
39%
Loosely correlated
-4.30%
More